Lung Cancer Clinical Trials in Oklahoma, OK

If you decide to join, you’ll first be asked to sign an Informed Consent Form that describes all study procedures, potential risks, and your rights. Our study team will walk you through everything and answer your questions before you enroll.

After giving consent, participants undergo screening to check eligibility, including lab tests, imaging, and a review of prior treatment and surgical pathology. Those who qualify are then randomized into one of the two study arms: the combination therapy group or the physician’s-choice group.

During the trial, you’ll attend regular follow-up visits. These will include physical exams, blood work, check-ins on side effects, and possibly imaging or other assessments. The care is conducted by experienced oncology specialists, and all study-related procedures are provided at no cost.

* Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.

If you decide to participate, you’ll begin by reviewing and signing an Informed Consent Form that outlines the study in clear detail. Our research team will walk you through each step, answer your questions, and help you feel confident about your choice to join or withdraw whenever you wish.

Throughout the study, experienced physicians will closely monitor your health through regular exams and evaluations. Your participation may contribute to advancing future treatment options for people with resectable Stage II to IIIB lung cancer.

Hightower Clinical is conducting a colorectal cancer BMI clinical trial in Oklahoma City for adults 18+ with newly diagnosed metastatic colorectal cancer and a BMI between 18–29 kg/m². The study is evaluating an investigational daily injectable treatment alongside chemotherapy to help preserve muscle and fat mass, support healthy body composition, and improve physical resilience during treatment. Participants may benefit from close medical monitoring, access to advanced care, and the opportunity to contribute to research aimed at enhancing treatment tolerance and recovery outcomes in colorectal cancer.